Fresenius reported EUR5.59B in Operating Expenses for its fiscal quarter ending in December of 2023.

Operating Expenses Change Date
AstraZeneca USD 9.54B 578M Sep/2023
BASF EUR 15.34B 991M Sep/2023
Beiersdorf EUR 4.07B 146M Jun/2023
Demant DKK 9.14B 552M Jun/2023
Essilor EUR 11.02B 35M Jun/2023
Givaudan CHF 2.95B 35M Jun/2023
Hikma Pharmaceutical USD 1.18B 60M Jun/2023
Lonza CHF 2.54B 193M Jun/2023
Roche Holding CHF 20.02B 5.04B Jun/2023
RWE EUR 4.37B 956M Sep/2023
Smith & Nephew USD 2.46B 52M Jun/2023